Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-30 | Dr. Stump was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc. |
| 2015-04-09 | Dr. Stump received an A.B. from Earlham College, an M.D. from Indiana University School of Medicine and completed his internship and residency in Internal Medicine as well as his fellowship in Hematology and Oncology. |
| 2016-04-07 | Dr. Stump has served as a director since September 2013. Dr. Stump was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc., where he was employed from November 1999 until his retirement in December 2012. Dr. Stump also serves as a director of Sunesis Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., and REGENXBIO, Inc., which are publicly-held companies. The Board believes that Dr. Stump’s medical training and 23 years of experience in research and development and operations in the biotechnology industry qualify him to serve as a member of our Board. |
| 2017-04-04 | Dr. Stump was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc., where he was employed from November 1999 until his retirement in December 2012. Dr. Stump also serves as a director of Sunesis Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., and REGENXBIO, Inc., which are publicly held companies. |
| 2018-04-06 | Dr. Stump was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc., where he was employed from November 1999 until his retirement in December 2012. Dr. Stump also serves as a director of Sunesis Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., and REGENXBIO, Inc., which are publicly held companies. The Board believes that Dr. Stump’s medical training and 23 years of experience in research and development and operations in the biotechnology industry as well as his public company board service qualify him to serve as a member of our Board. |
| 2019-04-05 | Dr. Stump was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc... The Board believes that Dr. Stump’s medical training and 23 years of experience in research and development... qualify him to serve as a member of our Board. |
| 2020-04-03 | Dr. Stump has served as a director since September 2013. Dr. Stump was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc., where he was employed from November 1999 until his retirement in December 2012. Dr. Stump also serves as a director of Sunesis Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., and REGENXBIO, Inc., which are publicly held companies. |
| 2021-04-02 | Dr. Stump’s medical training and 23 years of experience in research and development and operations in the biotechnology industry. |
| 2022-04-08 | He holds an A.B. from Earlham College and an M.D. from Indiana University and completed his residency fellowship training in internal medicine, hematology, oncology, and biochemistry at the University of Iowa. |
| 2023-04-17 | He holds an A.B. from Earlham College and an M.D. from Indiana University. |
| 2024-04-08 | He holds an A.B. from Earlham College and an M.D. from Indiana University and completed his residency and fellowship training in internal medicine, hematology, oncology, and biochemistry at the University of Iowa. |
Data sourced from SEC filings. Last updated: 2026-02-03